Article Information
History
- August 4, 2020.
Article Versions
- You are currently viewing Version 1 of this article (August 4, 2020 - 06:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Erik M. Volz1,*,
- Verity Hill2,
- JT McCrone2,
- Anna Price3,
- David Jorgensen1,
- Áine O’Toole2,
- Joel Southgate3,
- Robert Johnson1,
- Ben Jackson2,
- Fabricia F. Nascimento1,
- Sara M. Rey4,
- Samuel M. Nicholls5,
- Rachel M. Colquhoun2,
- Ana Da Silva Filipe8,
- Nicole Pacchiarini4,
- Matthew Bull4,
- Lily Geidelberg1,
- Igor Siveroni1,
- Ian G. Goodfellow6,
- Nicholas J. Loman5,
- Oliver Pybus7,
- David L. Robertson8,
- Emma C. Thomson8,
- Andrew Rambaut2,*,
- Thomas R. Connor3,4,9,* and
- on behalf of the CoG-UK consortium10
- 1Department of Infectious Disease Epidemiology and MRC Centre for Global Infectious Disease Analysis, Imperial College London
- 2Institute of Evolutionary Biology, University of Edinburgh
- 3School of Biosciences, Cardiff University
- 4Pathogen Genomics Unit, Public Health Wales NHS Trust
- 5Institute of Microbiology and Infection, University of Birmingham
- 6Department of Pathology, University of Cambridge
- 7Department of Zoology, University of Oxford
- 8MRC-University of Glasgow Centre for Virus Research
- 9Quadram Institute Bioscience
- ↵*Correspondence should be addressed to: e.volz{at}imperial.ac.uk, a.rambaut{at}ed.ac.uk and ConnorTR{at}cardiff.ac.uk
Posted August 04, 2020.
Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity
